New York State Common Retirement Fund Portfolio holdings
AUM
$75.2B
1-Year Return
24.38%
This Quarter Return
-14.97%
1 Year Return
+24.38%
3 Year Return
+108.85%
5 Year Return
+192%
10 Year Return
+482.31%
AUM
$76.6B
AUM Growth
-$16.9B
(-18%)
Cap. Flow
-$991M
Cap. Flow
% of AUM
-1.29%
Top 10 Holdings %
Top 10 Hldgs %
22.59%
Holding
3,646
New
299
Increased
1,012
Reduced
2,108
Closed
73
Top Buys
| 1 |
Linde
LIN
|
$242M |
| 2 |
ConocoPhillips
COP
|
$73.9M |
| 3 |
Airbnb
ABNB
|
$57.9M |
| 4 |
Salesforce
CRM
|
$52.5M |
| 5 |
Chevron
CVX
|
$52M |
Top Sells
| 1 |
Apple
AAPL
|
$128M |
| 2 |
Alphabet (Google) Class C
GOOG
|
$104M |
| 3 |
AT&T
T
|
$99.3M |
| 4 |
UnitedHealth
UNH
|
$80.8M |
| 5 |
NXP Semiconductors
NXPI
|
$65.7M |
Sector Composition
| 1 | Technology | 24.72% |
| 2 | Healthcare | 15.98% |
| 3 | Financials | 13.42% |
| 4 | Consumer Discretionary | 10.38% |
| 5 | Industrials | 8.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3326
Heritage Insurance Holdings
HRTG
$747M
| $1K | ﹤0.01% |
233
-7,785
| -97% | -$33.4K |
|
|
ICAD
3327
DELISTED
iCAD Inc
ICAD
| $1K | ﹤0.01% |
185
-14,400
| -99% | -$77.8K |
|
|
IMA
3328
ImageneBio, Inc. Common Stock
IMA
$89M
| $1K | ﹤0.01% |
17
-1,822
| -99% | -$107K |
|
3329
Immuneering
IMRX
$229M
| $1K | ﹤0.01% |
165
-4,472
| -96% | -$27.1K |
|
3330
Immunic
IMUX
$75.1M
| $1K | ﹤0.01% |
156
-9,878
| -98% | -$63.3K |
|
3331
InfuSystem Holdings
INFU
$208M
| $1K | ﹤0.01% |
104
-13,365
| -99% | -$129K |
|
|
INZY
3332
DELISTED
Inozyme Pharma
INZY
| $1K | ﹤0.01% |
117
-3,717
| -97% | -$31.8K |
|
3333
Kaltura
KLTR
$226M
| $1K | ﹤0.01% |
500
-2,750
| -85% | -$5.5K |
|
3334
Kopin
KOPN
$345M
| $1K | ﹤0.01% |
676
-52,500
| -99% | -$77.7K |
|
3335
KVH Industries
KVHI
$116M
| $1K | ﹤0.01% |
105
-3,636
| -97% | -$34.6K |
|
3336
Standard BioTools
LAB
$497M
| $1K | ﹤0.01% |
546
-51,819
| -99% | -$94.9K |
|
3337
Lineage Cell Therapeutics
LCTX
$279M
| $1K | ﹤0.01% |
907
-68,222
| -99% | -$75.2K |
|
3338
Limoneira
LMNR
$285M
| $1K | ﹤0.01% |
101
-8,236
| -99% | -$81.5K |
|
3339
Mayville Engineering Co
MEC
$302M
| $1K | ﹤0.01% |
75
-6,900
| -99% | -$92K |
|
3340
MEI Pharma
MEIP
$139M
| $1K | ﹤0.01% |
47
-2,673
| -98% | -$56.9K |
|
3341
Mesa Air Group
MESA
$54M
| $1K | ﹤0.01% |
289
-19,700
| -99% | -$68.2K |
|
3342
Mistras Group
MG
$307M
| $1K | ﹤0.01% |
163
-8,365
| -98% | -$51.3K |
|
|
KG
3343
Kestrel Group, Ltd.
KG
$200M
| $1K | ﹤0.01% |
21
-1,774
| -99% | -$84.5K |
|
3344
Matrix Service
MTRX
$403M
| $1K | ﹤0.01% |
175
-16,162
| -99% | -$92.4K |
|
3345
Nathan's Famous
NATH
$429M
| $1K | ﹤0.01% |
20
-2,307
| -99% | -$115K |
|
3346
National CineMedia
NCMI
$411M
| $1K | ﹤0.01% |
60
-2,568
| -98% | -$42.8K |
|
3347
NN Inc
NNBR
$125M
| $1K | ﹤0.01% |
365
-20,200
| -98% | -$55.3K |
|
|
IMDX
3348
Insight Molecular Diagnostics Inc. Common Stock
IMDX
$71M
| $1K | ﹤0.01% |
29
-1,775
| -98% | -$61.2K |
|
3349
Oil-Dri
ODC
$934M
| $1K | ﹤0.01% |
64
-10,622
| -99% | -$166K |
|
3350
Olema Pharmaceuticals
OLMA
$570M
| $1K | ﹤0.01% |
207
-17,600
| -99% | -$85K |
|